Atropine sulfate (intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Atropine sulfate (intravenous), covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [Phase 4]